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Abstract
MT4-MMP is a membrane-type metalloproteinase (MMP) anchored to the membrane by a glycosyl-phosphatidylinositol
(GPI) motif. GPI-type MT-MMPs (MT4- and MT6-MMP) are related to other MT-MMPs, but their physiological substrates and
functions in vivo have yet to be identified. In this manuscript we show that MT4-MMP is expressed early in kidney
development, as well as in the adult kidney, where the highest levels of expression are found in the papilla. MT4-MMP null
mice had minimal renal developmental abnormalities, with a minor branching morphogenesis defect in early embryonic
kidney development and slightly dysmorphic collecting ducts in adult mice. Interestingly, MT4-MMP null mice had higher
baseline urine osmolarities relative to wild type controls, but these animals were able to concentrate and dilute their urines
normally. However, MT4-MMP-null mice had decreased daily water intake and daily urine output, consistent with primary
hypodipsia. MT4-MMP was shown to be expressed in areas of the hypothalamus considered important for regulating thirst.
Thus, our results show that although MT4-MMP is expressed in the kidney, this metalloproteinase does not play a major role
in renal development or function; however it does appear to modify the neural stimuli that modulate thirst.
Citation: Srichai MB, Colleta H, Gewin L, Matrisian L, Abel TW, et al. (2011) Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) Modulates Water Homeostasis
in Mice. PLoS ONE 6(2): e17099. doi:10.1371/journal.pone.0017099
Editor: Vladimir Uversky, University of South Florida College of Medicine, United States of America
Received November 30, 2010; Accepted January 19, 2011; Published February 11, 2011
Copyright:  2011 Srichai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was funded by NIH Grants DK075594, DK083187, DK62794 and the George O’Brien Center Grant from NIDDK. The studies were performed
from funds from these three RO1 grants to RZ and RCH. In addition much of the phenotyping was done by the renal physiology core of the George O’Brien Center
Grant; American Heart Association, established investigator award (RZ). RZ has a career award from the AHA. Funding also came from Veterans Affairs, Career
Development Award (MBS) and Merit awards (RZ, AP, RCH). All these investigators hold positions at the VA and thus were partially funded by the VA to do these
studies; funding also came from the National Kidney Foundation Fellowship Award (LG). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: roy.zent@vanderbilt.edu
Introduction
The matrix metalloproteinases (MMP) are a 23 member family
of zinc-binding endopeptidases that primarily function as promot-
ers of extracellular matrix degradation and are collectively
responsible for tissue remodeling during embryogenesis, organo-
genesis, tissue regeneration, wound healing and many other
physiologic and pathologic conditions. All MMPs are multidomain
enzymes with a common conserved domain structure consisting of
a prodomain, a catalytic domain, a hinge region, and a
hemopexin-like domain. Seventeen members are secreted as
soluble enzymes while 6 members are membrane-type MMPs
(MT-MMP), which are either associated with the cell membrane
by a type I transmembrane domain (MT1-MT3 and MT5) or are
glycosyl-phosphatidyl inositol (GPI)-anchored (MT4 and MT6).
While MT1-, MT2-, MT3- and MT5-MMP display potent
proteolytic activity towards ECM components, [1,2], the GPI-
anchored MT-MMPs, including MT4-MMP and MT6-MMP do
not possess clear proteolytic activity towards ECM substrates.
MT4-MMP has the least degree of sequence identity to the other
MMP family members and little is known about its function [3,4]. It
lacks a cytoplasmic tail suggesting it may have different functional
capabilities, and consistent with this it is unable to activate pro-
MMP2 [5]. The only well-defined substrate for MT4-MMP is
ADAMTS4, which has tumor necrosis factor-alpha convertase
activity; however the functional significance of this interaction is
unknown. Although studies have shown a role for MT4-MMP in
promoting cancer metastasis in breast [6] and glial cancers [7], the
mechanisms for these actions are still undetermined.
MT4-MMP is expressed in many areas of the body with highest
levels seen in the brain (particularly in the cerebrum), colon, ovary,
andtestis[3,8].However,wehavedeterminedthatthereisalsohigh
expression of MT4-MMP in the kidney papilla (current manu-
script). Numerous MMPs are expressed in the kidney in a poorly
characterizedand complex pattern. TheonlyMMP shown to play a
role in renal development in vivo is MT1-MMP, where the null mice
develop dysmorphic and dysgenic kidneys [9]. Although MMPs do
not play a major role in development, they have been implicated in
both acute kidney injury as well as in chronic kidney diseases,
including polycystic kidney disease, glomerulosclerosis/tubulointer-
stitial fibrosis, chronic allograft nephropathy, diabetic nephropathy,
and renal cell carcinoma [10]. Most of these studies demonstrated
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17099Figure 1. MT4-MMP localization in the mouse kidney. (A–B) b-galactosidase staining kidneys from 5week old MT4-MMP null mice shows
staining in the cortex and medulla (A, 50X DIC) with the most intense staining seen in the papilla (B, 200X DIC). (C–F) Staining with a specific antibody
directed against MT4-MMP in wildtype mice shows expression throughout the metanephric mesenchyme and ureteric bud at E12.5 (C, 100X). MT4-
MMP expression is abundant in the cortical regions during embryonic development (E18.5, D, 50X), but by 2weeks of age, most of the expression is
localized to the papilla regions (E–F, 50X and 200X, respectively). (G–H) Staining with a specific antibody directed against MT4-MMP in MT4-MMP null
and wildtype mice, demonstrating specificity of the antibody for MT4-MMP (200X). (I–J) Immunoblot of inner medullary collecting duct cells derived
from wild type mice (IMCD), MT4-MMP null mice (Null) or IMCD cells from MT4-MMP null mice reconstituted with MT4-MMP (Recon), illustrating
specificity of the antibody for MT4-MMP (I). Ponceau staining was performed on the nitrocellulose of the immunoblot to demonstrate equal loading
of the lysates (J).
doi:10.1371/journal.pone.0017099.g001
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in vivo studies indicating beneficial effects of blocking MMP activity
in different models of kidney injury [11,12,13]. Based on the relative
scarcity of data on the role of MT4-MMP, particularly within the
kidney, we characterized MT4-MMP expression within the kidney
and describe interesting abnormalities associated with water
homeostasis observed in MT4-MMP deficient mice.
Methods
MT4-MMP null mice and general reagents
All procedures on animals were approved by the Institutional
Animal Care and Use Committee of Vanderbilt University and
conducted according to the NIH Guide for the Care and Use of
Laboratory Animals. This was covered by protocol number M/
04/219 from Vanderbilt Medical Center.
MT4-MMP null mice were described previously [8] and because
part of the mouse MT4-MMP genomic locus was substituted with
the bacterial LacZ gene we were able to monitor of MT4-MMP
expression by tracking b-gal expression. MT4-MMP null mice were
backcrossed onto the C57/BL6 strain (10
th generation) for all
experiments. C57/BL6 mice were purchased from Harlan
Laboratories. Genotyping of MT4-MMP mice was performed by
standard PCR with the following 3 primers: 1) MT4 forward 59-
CCAGGTGGCAGAGGTAAGTA-39; 2) MT4 new forward 59-
AAGGTGCTGAAGGTTCGAGA-39; and 3) MT4 reverse 59-
CAAGGAATAAGGTGAGCTTCAGAA-39, which yields a
180 bp wild-type band and a 350 bp knockout band. For urine
concentration studies, DDAVP (Sigma, St. Louis, MO) was
administered intraperitoneally as a onetime 10 ng dose and urine
was collected following 3 hours of water deprivation post-DDAVP.
Histology and Immunohistochemistry
All kidneys were fixed in 4% paraformaldehyde, paraffin-
embedded and 5 mm sections were cut for Hematoxylin & Eosin
or Periodic acid Schiff staining. Antibodies used included rabbit
anti-MT4 (1:200, Biovision, Mountain View, CA), rabbit anti-
AQP2 (1:250, Alpha Diagnostics, San Antonio, TX), rabbit anti-
AQP1 (1:250, Chemicon International, Billerica, MA), and rabbit
anti-ENaCb (gift from Mark Knepper, NIH).
b-gal staining
Adult mice were perfused-fixed in 4% paraformaldehyde, then
fixed for an additional 2 hours in 4% paraformaldehyde. Brain
and kidney sections were sliced and incubated in X-gal buffer
(5 mM potassium ferrocyanide, 5 mM potassium ferricyanide,
2 mM MgCl2, 0.01% deoxycholate acid, 0.02% NP-40, and 0.1%
X-gal) at 30uC overnight. Following PBS washing, tissues were
paraffin-embedded and sectioned. Brain sections were counter-
stained with hematoxylin and eosin to better define brain
structure. Kidney sections were left unstained.
Organ Culture
Kidneys from 12 day MT4-MMP-null or C57 embryos were
removed and grown on culture dishes in DMEM/F12 10% FBS
for 48 hr. Following attachment and growth, kidneys were stained
for E-cadherin (BD Biosciences, San Jose, CA) followed by FITC-
anti-rabbit and visualized using a fluorescent microscope (Olym-
pus, Center Valley, PA).
MT4-MMP null cell derivation
Collecting duct cells were isolated from MT4-MMP null and wildtype
mice following the methodology described by Husted et al. [14]. The
MT4-MMP null cells were transduced with a human c-DNA of MT4-
M M Pa n ds o r t e db yf l o wc y t o m e t ry for MT4-MMP expression.
Immunoblotting
The collecting duct cells were lysed with RIPA buffer after which
the lysates were clarified by centrifugation and 20 mg total protein
was electrophoresed onto an 10% SDS-PAGE and subsequently
transferred to nitrocellulose membranes. Membranes were blocked
in 5% milk/TBS Tween and then incubated with the MT4-MMP
primary antibody followed by an HRP-conjugated secondary
antibody. Immunoreactive bands were identified using enhanced
chemiluminescence according to the manufacturer’s instructions.
Quantification of glomerular number
Glomeruli were counted as previously described [15,16].
Briefly, individual kidneys were isolated from adult mice (.8
weeks of age) and minced into 2-mm cubes. Fragments were
incubated in 5 ml of 6 M HCl at 37uC for 90 min. Following
incubation, tissues were homogenized through repeated pipetting
and 25 ml of H2O added followed by overnight incubation at 4uC.
Tissues were stored at 4uC. To count glomeruli, 561 ml of this
solution was counted in a 35-mm counting dish.
Metabolic studies
Mice undergoing metabolic studies were acclimated to
metabolic cages (Hatteras, Cary, NC) for at least two days
Figure 2. Adult MT4-MMP null have subtle abnormalities in the
renal papilla. (A–B) No gross abnormalities are seen in low power
(50X) images of H and E stained kidneys from MT4-MMP null mice (A)
when compared to C57/BL6 controls (B). (C–F) Tubules in the deep
papilla of MT4-MMP null kidneys are less tightly packed and show
subtle evidence of disorganization (C, E). C–D, H&E, 200X; E–F, PAS,
400X. (G–H) The cortex of MT4-MMP null kidneys appear morpholog-
ically normal with no apparent decrease number of glomeruli, PAS,
200X.
doi:10.1371/journal.pone.0017099.g002
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and urine output were recorded.F o rc h r o n i cw a t e rl o a d i n g ,
mice were fed high water gel food [17] consisting of 19 ml of
gel diet containing 14.8 ml of water, 4 grams powdered food
(AIN-93G, Test diet, Richmond, IN) and 3.8% porcine gelatin
(Sigma-Aldrich, St. Louis, MO), daily for 1 week. Following
chronic water loading, mice were subjected to acute water
loading and administered 2 ml water intraperitoneally. Animals
were then water-restricted and urines collected hourly for urine
osmolarity. Urine osmolarity was measured with a urine
osmometer (Precision System s ,N a t i c k ,M A ) .i - S T A TE C - 8 +
cartridges (Heska, Loveland, CO) were used to measure whole
b l o o dB U Na n ds o d i u m( N a ) .
Statistical analysis
Data were analyzed using GraphPad Prism 5 for Windows
software. For statistical analysis of all parameters, the Mann-
Whitney t tests were used. For branching count analysis, the
number of branches from each embryo (average 6 per group) were
counted and compared between groups. Mann-Whitney test
statistical analysis was performed. For total glomerular number,
the average number per kidney was extrapolated mathematically
from the mean of five counts. At least 3 kidneys from each
genotype were counted and statistical analysis performed using the
Mann-Whitney test.
Results
MT4-MMP is expressed in the kidney
High levels of MT4-MMP expression in the kidney were not
observed in initial studies where MT4-MMP expression was
studied in mice [3,8]. However, characterization of adult MT4-
MMP null mice with b-galactosidase knocked into the MT4-
MMP locus showed that high levels of b-galactosidase were
expressed within the papilla of the kidney (Figure 1A–B) with less
expression in the cortex. To confirm these results, immunohis-
Figure 3. MT4-MMP null mice have a mild early embryonic branching morphogenesis defect when cultured in vitro. (A–B) MT4-MMP
null kidneys at P0 do not show a branching defect when compared to C57/BL6 control kidneys 50X, H&E. (C–D) E12.5 kidneys were dissected and
grown in organ culture for 72 hours and stained for E-cadherin. Fewer branches are seen in MT4-MMP null kidneys (C) compared to C57/BL6 controls
(D). (E) Quantification of branching number in kidney organ culture reveals MT4-MMP null kidneys have significantly less branching, ** p,0.05. (F)
Quantification of glomerular number in adult kidneys reveals no differences between the two genotypes.
doi:10.1371/journal.pone.0017099.g003
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performed in the kidney from early development (E12.5) to
adulthood. MT4-MMP is highly expressed within both the
ureteric bud and metanephric mesenchyme at embryonic day
12.5 (Figure 1C). At E18.5 expression is seen in both the cortical
and medullary tubules (Figures 1D) and by 2 weeks of age
expression is still present within the kidney cortex; however, the
majority of expression is localized to the collecting ducts in the
papilla (Figures 1E–F). The specificity of the MT4-MMP
antibody was confirmed by performing immunohistochemistry
on wild type and MT4-MMP null kidneys. As shown in figure 1G
there is only background none specific staining in the MT4-MMP
null kidneys, while there is intense staining in the wild type
kidneys (Figure 1H). To further confirm the specificity of the
antibody we performed immunoblots on inner medullary
collecting duct cells derived from wild type as well as MT4-
MMP null mice. As seen in figure 1I the antibody was
immunoreactive with lysates from cells derived from wild type
mice and cells from MT4-MMP null mice that were transduced
with human MT4-MMP. No immunoreactivity was observed in
the lane loaded with lysates of MT4-MMP null cells. Equal
loading of protein in each lane was verified by Ponceau staining
of the membrane (Figure 1J). Thus MT4-MMP expression in the
kidney changes during development, but the predominant region
of expression both in early development and postnatally is the
collecting system, which is derived from the ureteric bud.
MT4-MMP null adult kidneys have subtle abnormalities in
the deep papilla of the kidney
To determine whether deleting MT4-MMP in mice resulted in
a renal phenotype, we performed histological analysis on adult
kidneys. There were no gross anatomical abnormalities in the
kidney cortex or medulla in the MT4-MMP null mice (Figure 2A–
B); however, in the papilla there were subtle defects of collecting
duct cellular organization (Figure 2C–F) and a decrease in density
of tubules within the papilla. The cortex appeared similar in
wildtype and MT4-MMP null mice (Figure 2G–H). No differences
in Ki67, a marker of proliferation, were seen (data not shown).
Kidneys were assessed at different developmental stages from
E12.5 to P1. There were no significant developmental abnormal-
ities present in the MT4-MMP null kidneys during embryogenesis
(data not shown), and this was confirmed at P0 (Figure 3 A–B).
When embryonic day 12.5 kidneys were cultured in vitro for
72 hours, the MT4-MMP null kidneys displayed a mild but
statistically significant decrease in the number of branches as
compared to controls (Figure 3C–E). To define whether this subtle
in vitro branching phenotype resulted in a difference in nephron
number in adult kidneys, glomerular counts were performed on
8week old kidneys. No difference was evident between MT4-MMP
null and control kidneys (Figure 3F). Thus, although a mild
branching defect is present in an in vitro kidney culture model early
in development only a subtle disorganization in the renal papilla is
Figure 4. MT4-MMP null mice have increased urine osmolarity compared to control mice. (A) Urine osmolarity obtained at baseline (0)
and following 24 hr water deprivation (24) reveals that MT4-MMP null mice have higher baseline urine osmolarity (*p=0.0164) vs C57/BL6 time point
0. Both groups of animals appropriately concentrate their urines following water deprivation. (B) Plasma osmolarity, (C) Plasma sodium and (D) Blood
urea nitrogen were the same in both groups.
doi:10.1371/journal.pone.0017099.g004
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minor role in normal renal development.
MT4-MMP null mice have increased urine baseline urine osmolarities.
Although the phenotypic changes in the MT4-MMP deficient
kidneys were subtle, we observed that the urine of the MT4-MMP
null mice was consistently more concentrated than wildtype mice.
The average baseline osmolarity of wildtype mice was
1800 mosm/kg, but it was significantly higher (2400 mosm/kg)
in the MT4-MMP null mice (Figure 4A). However, following
24 hr water deprivation both groups of animals exhibited maximal
urinary concentration, with an osmolarity of approximately
3400 mosm/kg [18]. Similar results were noted when mice were
administered desmopressin; a synthetic replacement for vasopres-
sin (data not shown). To determine whether these differences in
urine osmolarity were due to alterations in serum osmolarity or
sodium these parameters were measured. Both of these parameters
(Figure 4B and C) were similar between the two groups. Serum
blood urea nitrogen (BUN) levels (Figure 4D) were also similar in
the wild type and MT4-MMP null mice demonstrating that the
renal function of these mice was normal.
Increased urinary osmolarity in MT4-MMP mice is due to
hypodipsia
To define the mechanisms whereby the MT4-MMP null mice
had consistently higher baseline urinary osmolarity, we placed
them in metabolic cages to monitor both intake and output of
water and solutes. The MT4-MMP null mice drank approximately
half the volume of water of wild type controls and produced 50%
less urine (Figures 5A and B). We next defined whether the MT4-
MMP null mice exhibited abnormalities in salt or water handling
by the kidney. Mice were fed diets containing normal salt (0.4%
Na), low-salt (0.03% Na) or high-salt (3.15% Na) contents, and
urine osmolarity was measured. Urine osmolarities were consis-
tently higher in MT4-MMP null mice (Figure 5C) regardless of
dietary salt intake, suggesting that these mice have no abnormal-
ities in salt handling by their kidneys.
To assess whether MT4-MMP null mice could appropriately
dilute their urine, mice were subjected to chronic water loading by
administration of a high water gelled diet for one week after which
they were administered an acute 2 ml intraperitoneal water load.
The mice were then water restricted, and serial urine osmolarity
was measured. Following chronic water loading, both groups of
mice were able to establish similar baseline urine osmolarities of
approximately 1000 mOsm/kg (Figure 5D, time 0). Within
3 hours of receiving an acute water load both groups of mice
diluted their urines to approximately 300 mOsm/kg (Figure 5D).
Subsequently, both groups appropriately concentrated their urines
at similar rates over the following 15 hours. Thus the mice have no
renal abnormalities with respect to diluting their urines after water
loading.
Figure 5. Metabolic studies show that MT4-MMP null mice dilute and concentrate urine normally. (A) 24 hour water intake (**p,0.01)
and (B) 24 hour urine output is decreased in MT4-MMP null mice (**p,0.01). (C) Baseline urine osmolarity is always higher in MT4-MMP null mice
compared to control (**p,0.05), regardless of dietary sodium content. (D) When mice were chronically water loaded for a week, MT4-MMP null mice
appropriately diluted their urines (0). When 2 ml of water was injected intraperitoneally MT4-MMP null mice diluted and concentrated their urines in
a similar fashion to C57/BL6 controls.
doi:10.1371/journal.pone.0017099.g005
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the principal water channels of the kidney or key regulators of
sodium reabsorption in the collecting duct of the kidney, we
performed immunostaining for aquaporin-1 (AQP1, Figure 6A–B),
aquaporin-2 (AQP2, Figure 6C–D) and the epithelial sodium
channel ENaC-b (Figure 6E–F). No obvious differences in
expression of these proteins were defined between MT4-MMP
null and control kidneys. These data further suggest that the MT4-
MMP null kidneys function normally with respect to regulating
sodium and water homeostasis.
MT4-MMP is expressed in osmoreceptors located in the
anterior hypothalamus of the brain
The data obtained from our metabolic cage studies suggested
that the increased serum osmolality of the MT4-MMP mice was
due to primary hypodypsia. We therefore performed b galacto-
sidase staining to determine MT4-MMP expression in the anterior
hypothalamus, which contains the thirst center of mice. As noted
previously, b-galactosidase was highly expressed in the brain,
especially the cortex (Figure 7A) where it was found in neurons
(Figure 7B). Although the level of expression was less than in the
cortex, scattered expression was found throughout the remainder
of the cerebrum including the hypothalamus (Figure 7C–D). At
high magnification, blue-staining was noted within neurons in the
anterior hypothalamic area, which regulates drinking behavior.
Thus it is plausible that MT4-MMP plays a role in the neural
regulation of thirst.
Discussion
MT4-MMP (MMP17) was discovered over 10 years ago [3],
however little is known regarding its natural substrates, expression
pattern and in vivo and in vitro functions. In this report, we show
that MT4-MMP-null mice have higher baseline urine osmolarities
and consume less water than wildtype controls. We demonstrate
that although MT4-MMP is expressed in the developing and adult
kidney, kidney development and function with respect to salt and
water homeostasis in MT4-MMP-null mice is normal. Finally we
show that MT4-MMP is expressed in areas of the anterior
hypothalamus of the brain responsible for regulating thirst. These
results suggest that although MT4-MMP does not play a major
role in kidney development or function, it may modulate the
sensation of thirst, which is regulated in the anterior hypothalamus
of the brain.
Like many of the MMPs, MT4-MMP is expressed in the kidney
but plays little role in renal development. Although our initial
phenotyping of E12.5 MT4-MMP null embryonic kidneys grown
on transwells showed a moderate branching phenotype, only
subtle morphological abnormalities in the papilla of the kidney
were noted. These results were similar to those seen for the
gelatinases where mice deficient for MMP-2 or MMP-9 or both
MMP-2 and MMP-9 do not have a renal phenotype, although in
vitro organ cultures did demonstrate that MMP-9 might play a role
in ureteric bud branching [19,20,21,22]. MT1-MMP is the only
MMP known to modulate renal development, and MT1-MMP
Figure 6. MT4-MMP null mice do not have abnormalities in aquaporin 1, 2 or ENaC expression. Immunostaining was performed for (A–
B) Aquaporin I, (C–D) Aquaporin 2, and (E–F) ENaCb (50X).
doi:10.1371/journal.pone.0017099.g006
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branching morphogenesis and a severe proliferation defect [9].
While it has been proposed that the lack of a renal phenotype in
the various MMP-null mice could be due to functional
redundancies, this is unlikely to be the case for MT4-MMP as it
is structurally distinct from other MMPs, including the MT-
MMPs. The catalytic domain of MT4-MMP only possesses 37%
identity (50% similarity) with that of MT1-MMP and the catalytic
domains of both GPI-linked MT-MMPs, MT4-MMP and MT6-
MMP, are only 56% identical and 77% homologous, further
suggesting substrate specificity for this MMP [23].
The MT4-MMP-null mice demonstrated an increase in urine
osmolarity. This contrasts with the low urine osmolarities found in
most urinary concentrating defects seen in mice where water
channels or urea transporters are deleted. MT4-MMP null mice
exhibited consistently higher urine osmolarities compared to wild-
type control mice regardless of dietary salt content. However, MT4-
MMP null mice subjected to overnight water restriction or to
desmopressin in conjunction with 3 hours water deprivation were
able to concentrate their urines to the expected maximal levels. In
addition, following chronic water administration, MT4-MMP null
mice were able to dilute their urines and excrete an acute water load
at the same rate as controls, suggesting that their ability to maximally
dilute their urines was intact. These findings indicated that despite
higher baseline urine osmolarities, a renal concentrating defect was
not present. These data strongly suggest that the mice had hypodipsia
due to a primary disorder affecting the sensation of thirst [24].
The hypodipsia noted in the MT4-MMP null mice was not
associated with abnormalities in serum electrolytes or an increase
in plasma osmolarity. Furthermore, the MT4-MMP null mice did
not have abnormalities in vasopressin secretion, as they could
appropriately concentrate their urines in response to water
deprivation. We also noted MT4-MMP expression in the anterior
hypothalamic areas of the brain, which is known to mediate thirst.
Thus the phenotype of the MT4-MMP-null mice is likely related
to a yet undetermined role for MT4-MMP in regulating thirst,
which is different from the mechanisms found in hypodipsic
hypernatremia seen in conditions such as intrahypothalamic
hemorrhage, primary neoplasms associated with the brain
(craniopharyngioma, pinealoma, meningioma), hydrocephalus,
and head injuries, which are associated with abnormal vasopressin
secretion [25].
There are genetic models of mice that have abnormalities with
drinking. For example mice that are null for the TRPV4 channel
have hypodipsia and associated hyperosmolarity. This channel is
expressed in the organum vasculosum of the lamina terminalis and
subfornical organ, which sense osmotic pressure and project to
neurons in the supraoptic and paraventricular nucleus of the
hypothalamus. Urine osmolarity was not measured in trpv4
-/-
mice, but they were noted to have lower antidiuretic hormone
levels compared to control mice [26], suggesting that TRPV4 is
necessary for the normal response to changes in osmotic pressure
and functions as an osmotic sensor in the CNS. This phenotype is
different from MT4-MMP null mice, which do not have
abnormalities with serum osmolality and MT4-MMP expression
is not seen in the paraventricular nucleus (data not shown). Thus
the underlying mechanisms for the hypodipsia between the
TRPV4-null and MT4-MMP null mice are likely to be different.
Figure 7. MT4-MMP is expressed in regions of the hypothalamus that regulate thirst. (A) b-gal staining of MT4-MMP null mouse brain
reveals intense blue staining. No staining is present in the wildtype controls. (B) b-gal staining is mainly within the cortex of the MT4-MMP null mice
(12.5X). (C) b-gal staining is present in scattered neurons within the hypothalamus (100X), including the anterior hypothalamic area and lateral
hypothalamic area, which are known to regulate thirst. (D) Inset shows high power view (400X) of the hypothalamus revealing blue staining within
neurons.
doi:10.1371/journal.pone.0017099.g007
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expressed in the mouse kidney and brain; however it only plays a
minor role in renal development and function. Despite the normal
kidney function, the MT4-MMP null mice demonstrate hypodip-
sia and consequently develop increased urine osmolarity, which we
believe is likely due to disrupted thirst regulation within the
anterior hypothalamus of the brain.
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